Citation Impact

Citing Papers

p53: puzzle and paradigm.
1996 Standout
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
2008
Transition in Specification of Embryonic Metazoan DNA Replication Origins
1995 StandoutScience
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Chromatin Reader Brd4 Functions in Ig Class Switching as a Repair Complex Adaptor of Nonhomologous End-Joining
2014 StandoutNobel
Transcription factors and the control of DNA replication
1992
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
The transactivator proteins VP16 and GAL4 bind replication factor A
1993
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
1999 StandoutNobel
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Head and neck cancer
2008 Standout
Viruses in human cancers
1999 StandoutNobel
THE GENETIC PROGRAM OF GENITAL HUMAN PAPILLOMAVIRUSES IN INFECTION AND CANCER
1996
Transcriptional control of human papillomavirus type 18 oncogene expression in different cell lines: Role of transcription factor YY1
1995 StandoutNobel
Oncogenic activities of human papillomaviruses
2009
Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation
2009
Characterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4
1997 StandoutNobel
The human papillomavirus E7 oncoprotein
2008
Viruses in human cancers
1999 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Functions of Human Papillomavirus Proteins
1994
Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor
2004
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Insights into Strand Displacement and Processivity from the Crystal Structure of the Protein-Primed DNA Polymerase of Bacteriophage φ29
2004 StandoutNobel
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
2010 StandoutNobel
Bovine papillomaviral gene expression in equine sarcoid tumours
1999
Papillomaviruses in Human Cancers
1999 StandoutNobel
Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human Sμbp-2 protein in glial cells
1997 StandoutNobel
The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication
1993
Oncogenic DNA viruses
2001 StandoutNobel
Human Papillomaviruses and Cervical Cancer
2006
SUMO-1 Modification of Bovine Papillomavirus E1 Protein Is Required for Intranuclear Accumulation
2000
Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose
1998 StandoutNobel
Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition
2000 StandoutNobel
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter
1995 StandoutNobel
Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein.
1992
Differential Requirements for Conserved E2 Binding Sites in the Life Cycle of Oncogenic Human Papillomavirus Type 31
1998
Genital warts in Burmeister's porpoises: characterization of Phocoena spinipinnis papillomavirus type 1 (PsPV-1) and evidence for a second, distantly related PsPV
2007
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
1995 StandoutNobel
Abrogation of the Brd4-Positive Transcription Elongation Factor b Complex by Papillomavirus E2 Protein Contributes to Viral Oncogene Repression
2009
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Yeast Nucleotide Excision Repair Proteins Rad2 and Rad4 Interact with RNA Polymerase II Basal Transcription Factor b (TFIIH)
1994 StandoutNobel
Initiation and termination of DNA replication in human rRNA genes.
1993
Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle
1997
Yeast nucleotide excision repair proteins Rad2 and Rad4 interact with RNA polymerase II basal transcription factor b (TFIIH).
1994 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein
1997
Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro.
1995
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
In Vitro Analysis of the Role of Replication Protein A (RPA) and RPA Phosphorylation in ATR-mediated Checkpoint Signaling
2012 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Protein Modification by SUMO
2004 Standout
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
Structure and Function of Hexameric Helicases
2000
In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
1996
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Specific transcription factors stimulate simian virus 40 and polyomavirus origins of DNA replication.
1992
A Promoter Region Mutation Affecting Replication of the Tetrahymena Ribosomal DNA Minichromosome
1998 StandoutNobel

Works of Ene Ustav being referenced

Genomic instability of the host cell induced by the human papillomavirus replication machinery
2007
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
2009
Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator.
1996
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.
1993
Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1.
1991
Induction of the Bovine Papillomavirus Origin “Onion Skin”-Type DNA Replication at High E1 Protein Concentrations In Vivo
2002
Rankless by CCL
2026